Akeila Bio is a biotech start-up company developing breakthrough, next-generation RXR agonists to treat a broad range of disease areas and indications with continuing and critical unmet medical needs.
Akeila Bio is a biotech start-up company developing breakthrough, next-generation RXR agonists to treat a broad range of disease areas and indications with continuing and critical unmet medical needs.